for the Period Ended 31 March 2024
Balance sheet | |
Notes |
As at
Notes |
2024 |
2023 |
|
---|---|---|---|
|
£ |
£ |
|
Fixed assets | |||
Investments: | 3 |
|
|
Total fixed assets: |
|
|
|
Current assets | |||
Debtors: |
|
|
|
Cash at bank and in hand: |
|
|
|
Total current assets: |
|
|
|
Creditors: amounts falling due within one year: |
( |
( |
|
Net current assets (liabilities): |
( |
( |
|
Total assets less current liabilities: |
|
|
|
Creditors: amounts falling due after more than one year: |
( |
( |
|
Total net assets (liabilities): |
|
|
|
Capital and reserves | |||
Called up share capital: |
|
|
|
Revaluation reserve: | 4 | ||
Profit and loss account: |
( |
( |
|
Shareholders funds: |
|
|
The notes form part of these financial statements
The directors have chosen to not file a copy of the company’s profit & loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 March 2024
for the Period Ended 31 March 2024
2024 | 2023 | |
---|---|---|
Average number of employees during the period |
|
|
for the Period Ended 31 March 2024
Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss
for the Period Ended 31 March 2024
2024 | |
---|---|
£ | |
Balance at 01 April 2023 | |
Surplus or deficit after revaluation | |
Balance at 31 March 2024 |